(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-([1,1'-biphenyl]-3-yl)propanoic acid, 97%, 5g

N-(2,2-Dimethoxyethyl)methacrylamide, 95+%, 1g

Methyl 6-chloropyrimidine-4-carboxylate, 97.0%, 25g

tert-Butyl 7-amino-5-oxa-2-azaspiro[3.4]octane-2-carboxylate, 97%, 5g

tert-Butyl (3aR,6aS)-tetrahydrocyclopenta[d][1,2,3]oxathiazole-3(3aH)-carboxylate 2,2-dioxide, 95%, 50mg

Fmoc-D-Tyr(4-Et)-OH, 1g

Glass vials with rolled rim Tall, 5 ml, Height, 40 mm, 200 Piece(s)

tert-butyl (3R)-3-fluoro-4-oxopiperidine-1-carboxylate, 95.0%, 5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(((benzyloxy)carbonyl)amino)butanoic acid, 97%, 100g

(R)-2-Benzo[1,3]dioxol-5-yl-thiazolidine-4-carboxylic acid, 1g

Crotyl Alcohol (cis- and trans- mixture)>95.0%(GC)25mL

Ethyl 8-bromo-3-methylimidazo[1,2-a]pyridine-2-carboxylate, 98%, 250mg

3,4,5-Trimethoxy-benzaldehyde, min. 98%, 25 g, glass packaging